What to Expect From Univar Solutions’ Upcoming Q4 Results?
Analysts at Berenberg Bank provided their views on Univar Solutions Inc. (NYSE:UNVR) ahead of the company’s Q4 results, expected to be reported on Feb 24.
The analysts anticipate strong earnings and believe that street estimates look realistic, if not conservative. While being in line for Q4 EBITDA, the analysts think that there is scope for an upside surprise to Q1 and 2022 guidance.
The company, along with other chemical distribution businesses, has been able to prosper amid never-ending reports of supply-chain tightness, pressures and concerns. Moreover, with supply-chain tightness unlikely to abate in the near term, the analysts believe the company will continue to demonstrate profitability strength.
Longer-term, the analysts think that the group is home to a growing and under-appreciated ingredients and specialty chemical segment (peers of which trade on significantly higher multiples) that can drive growth. The analysts raised their price target on the company’s shares to $32.50 from $28, while maintaining their buy rating.
| Symbol | Price | %chg |
|---|---|---|
| BRPT.JK | 1655 | -0.3 |
| 051910.KS | 229000 | 7.64 |
| 051915.KS | 115700 | 7.78 |
| 4063.T | 4735 | -0.78 |
What to Expect From Univar Solutions’ Upcoming Q4 Results?
Analysts at Berenberg Bank provided their views on Univar Solutions Inc. (NYSE:UNVR) ahead of the company’s Q4 results, expected to be reported on Feb 24.
The analysts anticipate strong earnings and believe that street estimates look realistic, if not conservative. While being in line for Q4 EBITDA, the analysts think that there is scope for an upside surprise to Q1 and 2022 guidance.
The company, along with other chemical distribution businesses, has been able to prosper amid never-ending reports of supply-chain tightness, pressures and concerns. Moreover, with supply-chain tightness unlikely to abate in the near term, the analysts believe the company will continue to demonstrate profitability strength.
Longer-term, the analysts think that the group is home to a growing and under-appreciated ingredients and specialty chemical segment (peers of which trade on significantly higher multiples) that can drive growth. The analysts raised their price target on the company’s shares to $32.50 from $28, while maintaining their buy rating.
